These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Vitamin B6 in the treatment of pre-menstrual mastalgia. Smallwood J; Ah-Kye D; Taylor I Br J Clin Pract; 1986 Dec; 40(12):532-3. PubMed ID: 3307864 [No Abstract] [Full Text] [Related]
25. Spectrum of benign breast disorders in a university hospital. Khanna AK; Tapodar J; Misra MK J Indian Med Assoc; 1997 Jan; 95(1):5-8. PubMed ID: 9212559 [TBL] [Abstract][Full Text] [Related]
26. DES versus tamoxifen in advanced breast cancer. N Engl J Med; 1981 Apr; 304(17):1041-3. PubMed ID: 7010171 [No Abstract] [Full Text] [Related]
27. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients. Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302 [TBL] [Abstract][Full Text] [Related]
28. Tamoxifen for breast pain. Coney S N Z Med J; 1998 May; 111(1066):193-4. PubMed ID: 9640322 [No Abstract] [Full Text] [Related]
29. [Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer]. Gundersen S; Kvaløy S; Fosså SD; Høst H Tidsskr Nor Laegeforen; 1983 Sep; 103(27):1873-5. PubMed ID: 6359581 [No Abstract] [Full Text] [Related]
30. Another view of tamoxifen. Napoli M Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681 [No Abstract] [Full Text] [Related]
31. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer. Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P Oncology; 1988; 45(5):350-3. PubMed ID: 3045726 [TBL] [Abstract][Full Text] [Related]
32. Tamoxifen and breast cancer prevention: what should you tell your patients? Goel V CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176 [No Abstract] [Full Text] [Related]
33. Tamoxifen for the prevention of breast cancer: yes. Vogel VG; Saenz M Important Adv Oncol; 1995; ():187-200. PubMed ID: 7672805 [No Abstract] [Full Text] [Related]
34. Tamoxifen in the palliative treatment of advanced breast cancer. A clinical review. Orr JD; Macdonald JA; Thomson JW J R Coll Surg Edinb; 1979 May; 24(3):141-7. PubMed ID: 88517 [No Abstract] [Full Text] [Related]
35. Current status of post-chemotherapy tamoxifen in early breast cancer. Tolcher AW Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838 [TBL] [Abstract][Full Text] [Related]
36. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Jordan VC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908 [No Abstract] [Full Text] [Related]
38. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint. Fabian C Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909 [No Abstract] [Full Text] [Related]
39. Role of tamoxifen in the long-term treatment and prevention of breast cancer. Jordan VC Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292 [TBL] [Abstract][Full Text] [Related]
40. Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer. Prescrire Int; 2001 Jun; 10(53):76-7. PubMed ID: 11718168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]